Gmail Calendar Documents Reader Web more »
Help | Sign in
Go to Google Groups Home
  
Discussions for Novartis AG (ADR) View all discussions

Message from discussion FDA APPROVAL Diovan
The group you are posting to is a Usenet group. Messages posted to this group will make your email address visible to anyone on the Internet.
Your reply message has not been sent.
Your post was successful
 
From:
To:
Cc:
Followup To:
Add Cc | Add Followup-to | Edit Subject
Subject:
Validation:
For verification purposes please type the characters you see in the picture below or the numbers you hear by clicking the accessibility icon. Listen and type the numbers you hear
 
novartisconce...@gmail.com  
View profile  
 More options Dec 25 2007, 6:55 pm
From: novartisconce...@gmail.com
Date: Tue, 25 Dec 2007 15:55:29 -0800 (PST)
Local: Tues, Dec 25 2007 6:55 pm
Subject: Re: FDA APPROVAL Diovan
maybe positive but could there be other concerns?  novartis is cutting
5% of global workforce.
ortiz.i...@gmail.com wrote:
> I definitely will say that with the approval of Diovan is a positive
> hit for NVS; this will balance the slowing sales in USA market. By the
> other hand the European Union market seem that has more troubles than
> the USA market and caused a down grate to most of the lager capital
> value stocks.

> Given those two situations and the NVS reorganization, I will expect
> that NVS will raise aging in the second quarter of 2008.

> IOB Advisor

> johnzakha...@gmail.com wrote:
> > what do you guys think of the news?

> > http://money.cnn.com/news/newsfeeds/articles/newstex/AFX-0013-2139148...


    Reply to author    Forward  
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.

Google Home - Terms of Service - Privacy Policy

©2009 Google